Radiopharmaceuticals Market Report | Global Forecast To 2029 Search jobs Radiopharmaceuticals Market Report | Global Forecast To 2029 Rapid increase in PET and SPECT scanning machines availability is likely to result towards growing demand for radio therapeutics and radio diagnostic events across the globe in the near future. Apart from this, growth in technological improvements with regards to PET scanning devices is expected to further surge the production sales of radiopharmaceuticals across the globe in the coming years. Most importantly, high level of accessibility and awareness has been driving the revenue growth of radiopharmaceuticals market. A renowned research firm after a thoroughgoing analysis reached on to declare few facts and figures relating to radiopharmaceuticals market. The global market for radiopharmaceuticals is set to witness a healthy CAGR of 5% during the forecast period of 2019 – 2029. Increasing application of nuclear medicine in oncology will garner around half the market value share by the end of 2029. The profiled players that are operating in the radiopharmaceuticals market includes IBA Radiopharma Solutions, Nordion, Inc., GE Healthcare (General Electric Co.), Siemens Healthineers (Siemens AG), Eckert & Ziegler, Lantheus Holdings, Inc. and Advanced Accelerator Applications.